High-dose 131 I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience

ConclusionsConsolidation therapy with high-dose131I-mIBG for patients with 2nd CR showed good overall and progression-free survival. While the risks of radiation exposure must be considered, high-dose131I-mIBG therapy as consolidation therapy needs to be further investigated.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research